BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37263352)

  • 1. Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test.
    Flinck H; Aittoniemi J
    J Virol Methods; 2023 Sep; 319():114758. PubMed ID: 37263352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
    Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
    J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-SARS-CoV-2 respiratory viral detection and whole genome sequencing from COVID-19 rapid antigen test devices: a laboratory evaluation study.
    Moso MA; Taiaroa G; Steinig E; Zhanduisenov M; Butel-Simoes G; Savic I; Taouk ML; Chea S; Moselen J; O'Keefe J; Prestedge J; Pollock GL; Khan M; Soloczynskyj K; Fernando J; Martin GE; Caly L; Barr IG; Tran T; Druce J; Lim CK; Williamson DA
    Lancet Microbe; 2024 Apr; 5(4):e317-e325. PubMed ID: 38359857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19.
    Montalvo Villalba MC; Sosa Glaria E; Rodriguez Lay LLA; Valdés Ramirez O; Vallina García D; Arencibia Garcia A; Martinez Alfonso J; Menes Llerena DM; Torres Pérez L; Resik Aguirre SR; Guzman Tirado MG
    J Med Virol; 2022 Mar; 94(3):1001-1008. PubMed ID: 34676585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection.
    Pérez-García F; Romanyk J; Gómez-Herruz P; Arroyo T; Pérez-Tanoira R; Linares M; Pérez Ranz I; Labrador Ballestero A; Moya Gutiérrez H; Ruiz-Álvarez MJ; Cuadros-González J
    J Clin Virol; 2021 Apr; 137():104781. PubMed ID: 33639492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test.
    Wolters F; Grünberg M; Huber M; Kessler HH; Prüller F; Saleh L; Fébreau C; Rahamat-Langendoen J; Thibault V; Melchers WJG
    J Med Virol; 2021 Oct; 93(10):5798-5804. PubMed ID: 34050951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test.
    Katzman BM; Wockenfus AM; Kelley BR; Karon BS; Donato LJ
    Clin Biochem; 2023 Jul; 117():1-3. PubMed ID: 34798145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of 22 Rapid Lateral Flow Tests for SARS-CoV-2 Antigen Detection and Influence of "Variants of Concern": Implications for Clinical Use.
    Gourgeon A; Soulier A; Audureau É; Khouider S; Galbin A; Langlois C; Bouvier-Alias M; Rodriguez C; Chevaliez S; Pawlotsky JM; Fourati S
    Microbiol Spectr; 2022 Aug; 10(4):e0115722. PubMed ID: 35862982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals.
    Bayart JL; Gillot C; Dogné JM; Roussel G; Verbelen V; Favresse J; Douxfils J
    J Clin Virol; 2023 Apr; 161():105419. PubMed ID: 36905798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
    Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L
    J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community.
    Stohr JJJM; Zwart VF; Goderski G; Meijer A; Nagel-Imming CRS; Kluytmans-van den Bergh MFQ; Pas SD; van den Oetelaar F; Hellwich M; Gan KH; Rietveld A; Verweij JJ; Murk JL; van den Bijllaardt W; Kluytmans JAJW
    Clin Microbiol Infect; 2022 May; 28(5):695-700. PubMed ID: 34363945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus.
    Klajmon A; Olechowska-Jarząb A; Salamon D; Sroka-Oleksiak A; Brzychczy-Włoch M; Gosiewski T
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis.
    Zupin L; Fontana F; Clemente L; Ruscio M; Crovella S
    Braz J Microbiol; 2022 Sep; 53(3):1271-1277. PubMed ID: 35446012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the Diagnostic Performance of SARS-CoV-2 Rapid Antigen Tests in COVID-19 Patients].
    Tuyji Tok Y; Dinç HÖ; Akçin R; Daşdemir FO; Eryiğit ÖY; Demirci M; Gareayaghi N; Kuşkucu MA; Kocazeybek BS
    Mikrobiyol Bul; 2022 Apr; 56(2):251-262. PubMed ID: 35477228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus.
    Nordgren J; Sharma S; Olsson H; Jämtberg M; Falkeborn T; Svensson L; Hagbom M
    J Clin Virol; 2021 Jul; 140():104846. PubMed ID: 33971580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance.
    Blairon L; Cupaiolo R; Thomas I; Piteüs S; Wilmet A; Beukinga I; Tré-Hardy M
    J Med Virol; 2021 Oct; 93(10):5783-5788. PubMed ID: 34050945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.